Koyfin Home > Directory > Health Care > ANI Pharma Inc > Gross Margin

ANI Pharma Inc Gross Margin Chart (ANIP)

ANI Pharma Inc annual/quarterly Gross Margin from 2012 to 2020. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • ANI Pharma Inc Gross Margin for the quarter ending June 06, 2020 was $60m a -17.59% decrease of -11m year over year
  • ANI Pharma Inc Gross Margin for the last 12 months ending June 06, 2020 was $64m a -8.88% decrease of -6m year over year
  • ANI Pharma Inc Annual Gross Margin for 2019 was $69m a 4.14% increase of 3m from 2018
  • ANI Pharma Inc Annual Gross Margin for 2018 was $67m a 16.89% increase of 11m from 2017
  • ANI Pharma Inc Annual Gross Margin for 2017 was $55m a -20.53% decrease of -11m from 2016
Other Margins & Efficiency Metrics:
  • ANI Pharma Inc EBITDA Margin for the quarter ending December 12, 2018 was $35m a 9.45% increase of 3m year over year
  • ANI Pharma Inc Return on Capital % for the quarter ending December 12, 2018 was 7.35 a 41.37% increase of 3.04 year over year
  • ANI Pharma Inc Return on Equity % for the quarter ending December 12, 2018 was 11.15 a 54.43% increase of 6.07 year over year
View Chart On Koyfin

Quarterly ANIP Gross Margin Data

06/2020$60m
03/2020$56m
12/2019$63m
09/2019$71m
06/2019$71m
03/2019$72m
12/2018$65m
09/2018$69m
06/2018$65m
03/2018$55m

Annual ANIP Gross Margin Data

2019$69m
2018$67m
2017$55m
2016$67m
2015$83m
2014$80m
2013$67m
2012$55m
2011$58m